issues with glp 1 drugs GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity GLP-1RA Essentials in Gastroenterology: Side

GLP-1 injections have emerged as prominent treatment options for weight management

n = 39 in the conventional arm) who completed 5.4 years of median follow-up underwent vibration-controlled transient elastography (FibroScan) to provide evidence of steatosis (controlled attenuation parameter (CAP)) and fibrosis [liver stiffness measurement (LSM)], while 42 participants (25 in conventional and 17 in triple therapy arms) eventually underwent MRI-PDFF to estimate liver fat content [128]

Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes

A pilot study investigating the influence of glucagon-like peptide-1 receptor single nucleotide polymorphisms on gastric emptying rate in caucasian men

, no difference

Long-acting formulations reduce dosing frequency